Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 14 April 2000:
Vol. 288. no. 5464, pp. 287 - 293
DOI: 10.1126/science.288.5464.287
Prev | Table of Contents | Next

Pathways of Discovery

Infectious History

Joshua Lederberg

In this month's essay, Joshua Lederberg escorts readers on a many-century, transglobal history of the ever intimate and often harrowing cohabitation of humanity and microbes. According to Lederberg, the success of the "wonder drugs" of the 1950s led many to believe that the "war on microbes" had been fought and won, but the emergence of new infectious agents such as HIV and Ebola has shattered that illusion. Ultimate survival, he suggests, may require us humans to embrace a more microbial point of view, in which microbes and their human hosts constitute a "superorganism."

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Microbial community profiling for human microbiome projects: Tools, techniques, and challenges.
M. Hamady and R. Knight (2009)
Genome Res. 19, 1141-1152
   Abstract »    Full Text »    PDF »
Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues.
R. Wall, R P. Ross, F. Shanahan, L. O'Mahony, C. O'Mahony, M. Coakley, O. Hart, P. Lawlor, E. M Quigley, B. Kiely, et al. (2009)
Am. J. Clinical Nutrition 89, 1393-1401
   Abstract »    Full Text »    PDF »
The Human Intestinal Microbiome: A New Frontier of Human Biology.
M. Hattori and T. D. Taylor (2009)
DNA Res 16, 1-12
   Abstract »    Full Text »    PDF »
Clinical Phase 1 Testing of the Safety and Immunogenicity of an Epitope-Based DNA Vaccine in Human Immunodeficiency Virus Type 1-Infected Subjects Receiving Highly Active Antiretroviral Therapy.
C. C. Wilson, M. J. Newman, B. D. Livingston, S. MaWhinney, J. E. Forster, J. Scott, R. T. Schooley, and C. A. Benson (2008)
Clin. Vaccine Immunol. 15, 986-994
   Abstract »    Full Text »    PDF »
Symbiotic gut microbes modulate human metabolic phenotypes.
M. Li, B. Wang, M. Zhang, M. Rantalainen, S. Wang, H. Zhou, Y. Zhang, J. Shen, X. Pang, M. Zhang, et al. (2008)
PNAS 105, 2117-2122
   Abstract »    Full Text »    PDF »
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.
M.-E. Dumas, R. H. Barton, A. Toye, O. Cloarec, C. Blancher, A. Rothwell, J. Fearnside, R. Tatoud, V. Blanc, J. C. Lindon, et al. (2006)
PNAS 103, 12511-12516
   Abstract »    Full Text »    PDF »
Authors' response.
G. Raso, E. Holmes, B. H Singer, E. K N'goran, and J. Utzinger (2005)
Int. J. Epidemiol. 34, 222-223
   Full Text »    PDF »
Emerging Infectious Diseases: A Clear and Present Danger to Humanity.
A. S. Fauci (2004)
JAMA 292, 1887-1888
   Full Text »    PDF »
Bacterial biota in the human distal esophagus.
Z. Pei, E. J. Bini, L. Yang, M. Zhou, F. Francois, and M. J. Blaser (2004)
PNAS 101, 4250-4255
   Abstract »    Full Text »    PDF »
Colonic Bacterial Flora: Changing Understandings in the Molecular Age.
V. Mai and J. G. Morris Jr. (2004)
J. Nutr. 134, 459-464
   Abstract »    Full Text »    PDF »
Gene Conversion as a Source of Nucleotide Diversity in Plasmodium falciparum.
K. M. Nielsen, J. Kasper, M. Choi, T. Bedford, K. Kristiansen, D. F. Wirth, S. K. Volkman, E. R. Lozovsky, and D. L. Hartl (2003)
Mol. Biol. Evol. 20, 726-734
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)